Diagnostic Yield and Clinical Consequences of Implantable Loop Recorder Monitoring in a Real-World Tertiary Cardiovascular Center Under Restricted Reimbursement

Background/Objectives: Implantable loop recorders (ILRs) provide prolonged, remotely monitored rhythm surveillance, but restricted reimbursement limits access in several healthcare systems, including Poland. We evaluated the safety and diagnostic yield of ILR monitoring in a tertiary center without dedicated reimbursement. Methods: We retrospectively analyzed consecutive patients undergoing ILR implantation (March 2013–November 2023); all devices were remotely monitored. The primary endpoint was an arrhythmia-driven management change (a management change resulting from an ILR-documented arrhythmia), analyzed per patient and per implantation episode. Results: Fifty patients (median age 58.1 years; 52.0% female) underwent 51 implantations, mostly for unexplained syncope (82.4%). The median symptom-to-implantation interval was 36 (interquartile range [IQR] 9–102) months. Over a median of 1290 (IQR 507–1519) monitoring days, clinically relevant arrhythmias were detected in 35 patients (70.0%). An arrhythmia-driven management change occurred in 21 patients (42.0%, 95% confidence interval 29.4–55.8%; Kaplan–Meier estimate 26.1% at 12 months), and every underlying arrhythmia was first identified by remote monitoring. These changes comprised cardiac implantable electronic device implantation in 13 patients (26.0%), catheter ablation in 4 (8.0%) and pharmacotherapy modification in 8 (16.0%). There were no acute procedural complications; pocket infection required explantation of 2 devices, and one non-cardiac death occurred. Conclusions: In this selected cohort under restricted reimbursement, remotely monitored ILR surveillance had an acceptable safety profile and led to an arrhythmia-driven management change in more than two in five patients. These single-arm data cannot quantify the effects of reimbursement policy or remote monitoring but support prospective comparative and economic evaluation of broader ILR access.

Authors

Institutions

Publication Details

Journal
Healthcare
Published
2026-11-18
DOI
https://doi.org/10.3390/healthcare14223968
Primary Topic
Cardiovascular Syncope and Autonomic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic Yield and Clinical Consequences of Implantable Loop Recorder Monitoring in a Real-World Tertiary Cardiovascular Center Under Restricted Reimbursement

Marcin Grabowski, Maria Boszko, Jakub Kosma Rokicki, Piotr Wieniawski et al.
1 links
Healthcare
Cardiovascular Syncope and Autonomic Disorders
article

Diagnostic Yield and Clinical Consequences of Implantable Loop Recorder Monitoring in a Real-World Tertiary Cardiovascular Center Under Restricted Reimbursement

Marcin Grabowski, Maria Boszko, Jakub Kosma Rokicki, Piotr Wieniawski, Marcin Michalak, Andrzej Cacko, Patryk Pindlowski
article en

Abstract

Background/Objectives: Implantable loop recorders (ILRs) provide prolonged, remotely monitored rhythm surveillance, but restricted reimbursement limits access in several healthcare systems, including Poland. We evaluated the safety and diagnostic yield of ILR monitoring in a tertiary center without dedicated reimbursement. Methods: We retrospectively analyzed consecutive patients undergoing ILR implantation (March 2013–November 2023); all devices were remotely monitored. The primary endpoint was an arrhythmia-driven management change (a management change resulting from an ILR-documented arrhythmia), analyzed per patient and per implantation episode. Results: Fifty patients (median age 58.1 years; 52.0% female) underwent 51 implantations, mostly for unexplained syncope (82.4%). The median symptom-to-implantation interval was 36 (interquartile range [IQR] 9–102) months. Over a median of 1290 (IQR 507–1519) monitoring days, clinically relevant arrhythmias were detected in 35 patients (70.0%). An arrhythmia-driven management change occurred in 21 patients (42.0%, 95% confidence interval 29.4–55.8%; Kaplan–Meier estimate 26.1% at 12 months), and every underlying arrhythmia was first identified by remote monitoring. These changes comprised cardiac implantable electronic device implantation in 13 patients (26.0%), catheter ablation in 4 (8.0%) and pharmacotherapy modification in 8 (16.0%). There were no acute procedural complications; pocket infection required explantation of 2 devices, and one non-cardiac death occurred. Conclusions: In this selected cohort under restricted reimbursement, remotely monitored ILR surveillance had an acceptable safety profile and led to an arrhythmia-driven management change in more than two in five patients. These single-arm data cannot quantify the effects of reimbursement policy or remote monitoring but support prospective comparative and economic evaluation of broader ILR access.

HealthcareVol. 14(22)
Medical University of Warsaw (PL)
Good health and well-being
Cardiovascular Syncope and Autonomic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon